{"entity":{"type":"insider","cik":"0001639647","url":"/insider/0001639647","json_url":"/insider/0001639647.json","name":"Woodrow Adam","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":18,"first":"2017-07-06","last":"2022-12-22","span_basis":"filed_date"},"name_variants":[{"name":"Woodrow Adam","source":"filing","n_filings":18,"first_seen":"2017-07-06","last_seen":"2022-12-22"}],"transactions":[{"id":6205818,"accession":"0000904454-22-000655","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-22-000655","line_url":"/filing/0000904454-22-000655#line-2","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (President & Chief Commercial)","role_mark":"O","role_mark_label":"Officer (President & Chief Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6750.0,"shares_display":"6,750","price_per_share":1.99,"price_display":"1.99","price_state":"stated","total_value":13432.5,"total_display":"13,432.50","total_whole":"13,433","shares_owned_after":651284.0,"shares_owned_after_display":"651,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-22","scope":"insider"},{"id":6742358,"accession":"0000904454-22-000629","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-22-000629","line_url":"/filing/0000904454-22-000629#line-2","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (President & Chief Commercial)","role_mark":"O","role_mark_label":"Officer (President & Chief Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6253.0,"shares_display":"6,253","price_per_share":1.96,"price_display":"1.96","price_state":"stated","total_value":12255.88,"total_display":"12,255.88","total_whole":"12,256","shares_owned_after":635534.0,"shares_owned_after_display":"635,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-13","filed_date":"2022-12-14","scope":"insider"},{"id":6742352,"accession":"0000904454-22-000629","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-22-000629","line_url":"/filing/0000904454-22-000629#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (President & Chief Commercial)","role_mark":"O","role_mark_label":"Officer (President & Chief Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3820.0,"shares_display":"3,820","price_per_share":1.98,"price_display":"1.98","price_state":"stated","total_value":7563.6,"total_display":"7,563.60","total_whole":"7,564","shares_owned_after":641787.0,"shares_owned_after_display":"641,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-12","filed_date":"2022-12-14","scope":"insider"},{"id":6415239,"accession":"0000904454-22-000534","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-22-000534","line_url":"/filing/0000904454-22-000534#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (President & Chief Commercial)","role_mark":"O","role_mark_label":"Officer (President & Chief Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4563.0,"shares_display":"4,563","price_per_share":3.47,"price_display":"3.47","price_state":"stated","total_value":15833.61,"total_display":"15,833.61","total_whole":"15,834","shares_owned_after":645607.0,"shares_owned_after_display":"645,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-28","filed_date":"2022-11-01","scope":"insider"},{"id":4762319,"accession":"0000904454-21-000838","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-21-000838","line_url":"/filing/0000904454-21-000838#line-3","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (President & Chief Commercial)","role_mark":"O","role_mark_label":"Officer (President & Chief Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22624.0,"shares_display":"22,624","price_per_share":4.27,"price_display":"4.27","price_state":"stated","total_value":96604.48,"total_display":"96,604.48","total_whole":"96,604","shares_owned_after":462329.0,"shares_owned_after_display":"462,329","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-15","scope":"insider"},{"id":4762316,"accession":"0000904454-21-000838","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-21-000838","line_url":"/filing/0000904454-21-000838#line-2","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (President & Chief Commercial)","role_mark":"O","role_mark_label":"Officer (President & Chief Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10946.0,"shares_display":"10,946","price_per_share":4.37,"price_display":"4.37","price_state":"stated","total_value":47834.02,"total_display":"47,834.02","total_whole":"47,834","shares_owned_after":484953.0,"shares_owned_after_display":"484,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-14","filed_date":"2021-12-15","scope":"insider"},{"id":4762313,"accession":"0000904454-21-000838","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-21-000838","line_url":"/filing/0000904454-21-000838#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (President & Chief Commercial)","role_mark":"O","role_mark_label":"Officer (President & Chief Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6422.0,"shares_display":"6,422","price_per_share":4.42,"price_display":"4.42","price_state":"stated","total_value":28385.24,"total_display":"28,385.24","total_whole":"28,385","shares_owned_after":494899.0,"shares_owned_after_display":"494,899","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-15","scope":"insider"},{"id":5526541,"accession":"0000904454-21-000622","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-21-000622","line_url":"/filing/0000904454-21-000622#line-2","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (President & Chief Commercial)","role_mark":"O","role_mark_label":"Officer (President & Chief Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10975.0,"shares_display":"10,975","price_per_share":5.12,"price_display":"5.12","price_state":"stated","total_value":56192.0,"total_display":"56,192.00","total_whole":"56,192","shares_owned_after":501321.0,"shares_owned_after_display":"501,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-18","scope":"insider"},{"id":4406901,"accession":"0000904454-21-000520","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-21-000520","line_url":"/filing/0000904454-21-000520#line-2","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (President & Chief Commercial)","role_mark":"O","role_mark_label":"Officer (President & Chief Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17182.0,"shares_display":"17,182","price_per_share":9.7,"price_display":"9.70","price_state":"stated","total_value":166665.4,"total_display":"166,665.40","total_whole":"166,665","shares_owned_after":474796.0,"shares_owned_after_display":"474,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-04","filed_date":"2021-06-08","scope":"insider"},{"id":3033973,"accession":"0000904454-20-000820","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-20-000820","line_url":"/filing/0000904454-20-000820#line-2","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (President & Chief Commercial)","role_mark":"O","role_mark_label":"Officer (President & Chief Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12855.0,"shares_display":"12,855","price_per_share":6.71,"price_display":"6.71","price_state":"stated","total_value":86257.05,"total_display":"86,257.05","total_whole":"86,257","shares_owned_after":271273.0,"shares_owned_after_display":"271,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-15","scope":"insider"},{"id":3033967,"accession":"0000904454-20-000820","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-20-000820","line_url":"/filing/0000904454-20-000820#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (President & Chief Commercial)","role_mark":"O","role_mark_label":"Officer (President & Chief Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9045.0,"shares_display":"9,045","price_per_share":6.95,"price_display":"6.95","price_state":"stated","total_value":62862.75,"total_display":"62,862.75","total_whole":"62,863","shares_owned_after":284128.0,"shares_owned_after_display":"284,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-11","filed_date":"2020-12-15","scope":"insider"},{"id":2602086,"accession":"0000904454-20-000753","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-20-000753","line_url":"/filing/0000904454-20-000753#line-2","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (President & Chief Commercial)","role_mark":"O","role_mark_label":"Officer (President & Chief Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":5.93,"price_display":"5.93","price_state":"stated","total_value":88950.0,"total_display":"88,950.00","total_whole":"88,950","shares_owned_after":293173.0,"shares_owned_after_display":"293,173","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-13","filed_date":"2020-11-16","scope":"insider"},{"id":3076183,"accession":"0000904454-20-000361","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-20-000361","line_url":"/filing/0000904454-20-000361#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (President & Chief Commercial)","role_mark":"O","role_mark_label":"Officer (President & Chief Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4798.0,"shares_display":"4,798","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":22790.5,"total_display":"22,790.50","total_whole":"22,791","shares_owned_after":270673.0,"shares_owned_after_display":"270,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2020-05-14","scope":"insider"},{"id":8377108,"accession":"0000904454-19-000739","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-19-000739","line_url":"/filing/0000904454-19-000739#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (President & Chief Commercial)","role_mark":"O","role_mark_label":"Officer (President & Chief Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4401.0,"shares_display":"4,401","price_per_share":3.1,"price_display":"3.10","price_state":"stated","total_value":13643.1,"total_display":"13,643.10","total_whole":"13,643","shares_owned_after":207971.0,"shares_owned_after_display":"207,971","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-12","filed_date":"2019-12-16","scope":"insider"},{"id":7831525,"accession":"0000904454-19-000680","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-19-000680","line_url":"/filing/0000904454-19-000680#line-2","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (President & Chief Commercial)","role_mark":"O","role_mark_label":"Officer (President & Chief Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5322.0,"shares_display":"5,322","price_per_share":3.82,"price_display":"3.82","price_state":"stated","total_value":20330.04,"total_display":"20,330.04","total_whole":"20,330","shares_owned_after":212372.0,"shares_owned_after_display":"212,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-08","filed_date":"2019-10-08","scope":"insider"},{"id":7858423,"accession":"0000904454-19-000182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-19-000182","line_url":"/filing/0000904454-19-000182#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (VP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3331.0,"shares_display":"3,331","price_per_share":6.77,"price_display":"6.77","price_state":"stated","total_value":22550.87,"total_display":"22,550.87","total_whole":"22,551","shares_owned_after":144694.0,"shares_owned_after_display":"144,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-05","filed_date":"2019-02-07","scope":"insider"},{"id":6038958,"accession":"0000904454-18-000781","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-18-000781","line_url":"/filing/0000904454-18-000781#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (VP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3733.0,"shares_display":"3,733","price_per_share":6.76,"price_display":"6.76","price_state":"stated","total_value":25235.08,"total_display":"25,235.08","total_whole":"25,235","shares_owned_after":131775.0,"shares_owned_after_display":"131,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-12","filed_date":"2018-12-14","scope":"insider"},{"id":6514585,"accession":"0000904454-18-000661","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-18-000661","line_url":"/filing/0000904454-18-000661#line-2","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (VP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2659.0,"shares_display":"2,659","price_per_share":8.96,"price_display":"8.96","price_state":"stated","total_value":23824.64,"total_display":"23,824.64","total_whole":"23,825","shares_owned_after":135508.0,"shares_owned_after_display":"135,508","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-15","filed_date":"2018-10-16","scope":"insider"},{"id":6254416,"accession":"0000904454-18-000646","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-18-000646","line_url":"/filing/0000904454-18-000646#line-3","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (VP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8750.0,"shares_display":"8,750","price_per_share":9.82,"price_display":"9.82","price_state":"stated","total_value":85925.0,"total_display":"85,925.00","total_whole":"85,925","shares_owned_after":131667.0,"shares_owned_after_display":"131,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-03","filed_date":"2018-10-04","scope":"insider"},{"id":6817405,"accession":"0000904454-18-000287","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-18-000287","line_url":"/filing/0000904454-18-000287#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (VP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":12.7,"price_display":"12.70","price_state":"stated","total_value":72390.0,"total_display":"72,390.00","total_whole":"72,390","shares_owned_after":89167.0,"shares_owned_after_display":"89,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-09","filed_date":"2018-04-10","scope":"insider"},{"id":6619568,"accession":"0000904454-18-000136","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-18-000136","line_url":"/filing/0000904454-18-000136#line-2","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (VP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":13.77,"price_display":"13.77","price_state":"stated","total_value":151470.0,"total_display":"151,470.00","total_whole":"151,470","shares_owned_after":51367.0,"shares_owned_after_display":"51,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-06","filed_date":"2018-02-07","scope":"insider"},{"id":6619566,"accession":"0000904454-18-000136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-18-000136","line_url":"/filing/0000904454-18-000136#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (VP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":14.22,"price_display":"14.22","price_state":"stated","total_value":47395.26,"total_display":"47,395.26","total_whole":"47,395","shares_owned_after":62367.0,"shares_owned_after_display":"62,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider"},{"id":5052418,"accession":"0000904454-17-000493","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-17-000493","line_url":"/filing/0000904454-17-000493#line-2","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001639647","owner_name":"Woodrow Adam","owner_display_name":"Woodrow Adam","owner_url":"/insider/0001639647","role":"Officer (VP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3800.0,"shares_display":"3,800","price_per_share":23.5788,"price_display":"23.58","price_state":"stated","total_value":89599.44,"total_display":"89,599.44","total_whole":"89,599","shares_owned_after":65700.0,"shares_owned_after_display":"65,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-05","filed_date":"2017-07-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178711","name":"Paratek Pharmaceuticals, Inc.","url":"/issuer/0001178711","role":"Officer (President & Chief Commercial)","n_filings":18,"first_seen":"2017-07-06","last_seen":"2022-12-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001639647","retrieved_at":"2026-08-23T13:10:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}